Certolizumab Pegol OverviewCertolizumab pegol (CDP870, tradename Cimzia) is a biologic medication for the treatment of Crohn's disease, rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. It is a fragment of a monoclonal antibody specific to tumor necrosis factor alpha (TNF-α) and is manufactured by UCB. Contents 1 Medical uses 2 Method of action 3 Clinical trials 4 Side effects 5 References 6 Externa...
Read more Certolizumab Pegol Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Certolizumab_pegol
Recent Certolizumab Pegol Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 200mg